PFIZER: Drug Recall
Recall #D-0261-2024 · 12/21/2023
Class I: Dangerous
Recall Details
- Recall Number
- D-0261-2024
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- PFIZER
- Status
- Ongoing
- Date Initiated
- 12/21/2023
- Location
- New York, NY, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,546 vials
Reason for Recall
Presence of particulate matter: glass
Product Description
Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18
Distribution Pattern
Nationwide in the USA, Netherlands and Libya
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.